Clinical Trials in Breast Cancer
Research in a Nutshell
David Cameron is Professor of Oncology at Edinburgh University, and works in NHS Lothian’s cancer centre treating breast cancer patients. He currently has also the part time deputy director role within the Scottish Government funded Innovative Health Care Delivery Programme (IHDP) which seeks to improve on access to, and enhance the use of, routine data on cancer patients within NHS Scotland. David also chairs the Scottish National SACT programme board and Cancer SACT data group.
Internationally he is the chair of the Breast International Group Executive Board, a Brussels-based umbrella group of 57 worldwide academic/not-for-profit breast cancer trials’ groups, and the vice chair of the steering group of the Oxford-based Early Breast Cancer Clinical Trialists’ Group. He is active in a number of current and past national and international clinical trials in breast cancer.
Prof. Cameron’s first degree was in mathematics from the University of Cambridge, and he received his medical degree in 1986 from St. George’s Hospital Medical School, London. After completing a fellowship and MSc in Clinical Oncology at the University of Edinburgh, he received a M.D. with distinction in 1997 and completed his training as a medical oncologist that same year. Previous other roles have included being Director of the NIHR-funded English National Cancer Research Networks, Scottish CSO lead for clinical cancer research and Director of Cancer Services in NHS Lothian. He was also the clinical director of the Edinburgh Cancer Research UK centre and the Edinburgh Experimental Cancer Medicine Centre. He has been a member of several cancer research funding committees including INCA PHRC, PAIR (Sein), Cancer Research UK Science committee, Cancer Research UK Clinical Research Committee, and from time to time various NIHR funding bodies including EME, clinical trials fellows committee. He is on the advisory board of the ICR and Glasgow Clinical Trials Units, and formerly on the Bordeaux Institute Bergonie SIRIC and the Cardiff Cancer Clinical and Translational Research programmes advisory boards.
Principal Investigator, Professor of Medical Oncology